Saxenda (liraglutide) for the Treatment of Obesity

Saxenda (liraglutide (rDNA origin)) is a newly approved injection for the treatment of obesity and chronic weight management.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news